Author: Cao, Rui-Yuan; Xu, Yong-fen; Zhang, Tian-Hong; Yang, Jing-Jing; Yuan, Ye; Hao, Pei; Shi, Yi; Zhong, Jin; Zhong, Wu
Title: Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika Cord-id: sbf9qi6g Document date: 2017_2_3
ID: sbf9qi6g
Snippet: Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barré syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Foo
Document: Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barré syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Food and Drug Admistration-approved drug that is safe for pediatric use. Nitazoxanide and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and we identified that they exerts antiviral effect possibly by targeting the viral postattachment step.
Search related documents:
Co phrase search for related documents- loading buffer and ma billerica: 1
- loading buffer and ma billerica millipore: 1
- luminescent cell and madison wi: 1, 2
- luminescent cell and madison wi promega: 1, 2
- luminescent cell viability kit and madison wi: 1, 2
- luminescent cell viability kit and madison wi promega: 1, 2
- ma billerica and madison wi: 1
- ma billerica millipore and madison wi: 1
Co phrase search for related documents, hyperlinks ordered by date